Senate CJS Bill Delivers Wins on Kratom, Illegal Marijuana Grows and DEA Funding
The Senate CJS bill puts kratom on DEA’s radar, orders a probe of foreign-run marijuana grows and gives DEA $123 million more.
The Senate CJS bill puts kratom on DEA’s radar, orders a probe of foreign-run marijuana grows and gives DEA $123 million more.
The psychedelic fast-track is reportedly shelved, with no new FDA review vouchers since May and a dormant political council.
Charles Fain Lehman says the war on drugs does not deserve its reputation as a racist failure, calling it a noble if flawed experiment.
Federal hemp ban: Former Arkansas Gov. and DEA chief Asa Hutchinson calls hemp THC a child safety problem and urges Republicans to hold firm.
Pete Ricketts’ Nebraska Senate win headlined a midterm night in which Cotton, Ayotte, Pappas, Harris, Tong and Cuellar, all opponents of commercial THC, kept their seats.
The AMA kratom warning to FDA: botanicals like kratom and marijuana must prove safety in clinical trials, not ride hype onto shelves.
Sens. Lankford and Budd urge USPS to keep its ban on mailing marijuana as Georgia moves to ship medical cannabis to patients by mail.
The 2026 DEA Drugs of Abuse guide deleted the line that FDA never approved marijuana. Its own hearing record says state programs aren’t medicine.
SAM asks the D.C. Circuit to revive its suit against the Medicare hemp program, which gives seniors $500 a year in THC products.
The GAO drug scheduling report that paused marijuana rescheduling found DEA has no written policies and FDA uses professional judgment.